Henry Schein, Inc. (NASDAQ:HSIC) Receives Average Recommendation of “Hold” from Brokerages

Shares of Henry Schein, Inc. (NASDAQ:HSIC) have earned an average rating of “Hold” from the fourteen analysts that are covering the firm, Marketbeat reports. One research analyst has rated the stock with a sell recommendation, eight have given a hold recommendation and five have issued a buy recommendation on the company. The average 12-month target price among analysts that have issued ratings on the stock in the last year is $76.0769.

A number of equities research analysts have issued reports on HSIC shares. Weiss Ratings reiterated a “hold (c-)” rating on shares of Henry Schein in a research note on Friday, October 31st. JPMorgan Chase & Co. increased their target price on Henry Schein from $76.00 to $78.00 and gave the stock an “overweight” rating in a research report on Wednesday. Robert W. Baird reissued a “neutral” rating and set a $72.00 target price (down previously from $82.00) on shares of Henry Schein in a research note on Monday, July 14th. Baird R W downgraded Henry Schein from a “strong-buy” rating to a “hold” rating in a research note on Monday, July 14th. Finally, Barrington Research set a $79.00 price objective on shares of Henry Schein and gave the company an “outperform” rating in a research report on Wednesday.

Institutional Investors Weigh In On Henry Schein

A number of hedge funds have recently made changes to their positions in the company. CYBER HORNET ETFs LLC purchased a new position in Henry Schein during the 2nd quarter valued at approximately $25,000. MUFG Securities EMEA plc bought a new position in shares of Henry Schein during the 2nd quarter valued at approximately $27,000. ANTIPODES PARTNERS Ltd bought a new position in shares of Henry Schein during the 2nd quarter valued at approximately $43,000. Steph & Co. purchased a new position in shares of Henry Schein in the second quarter valued at $44,000. Finally, CX Institutional increased its position in Henry Schein by 107.3% in the second quarter. CX Institutional now owns 651 shares of the company’s stock worth $48,000 after purchasing an additional 337 shares during the last quarter. 96.62% of the stock is currently owned by hedge funds and other institutional investors.

Henry Schein Price Performance

NASDAQ HSIC opened at $70.06 on Friday. The company has a current ratio of 1.41, a quick ratio of 0.78 and a debt-to-equity ratio of 0.51. Henry Schein has a 12 month low of $60.56 and a 12 month high of $82.49. The stock has a market cap of $8.50 billion, a price-to-earnings ratio of 22.60, a PEG ratio of 2.06 and a beta of 0.84. The company’s 50 day moving average is $66.25 and its two-hundred day moving average is $68.65.

Henry Schein (NASDAQ:HSIC) last posted its quarterly earnings results on Tuesday, November 4th. The company reported $1.38 earnings per share for the quarter, topping analysts’ consensus estimates of $1.27 by $0.11. The business had revenue of $3.34 billion during the quarter, compared to analyst estimates of $3.28 billion. Henry Schein had a net margin of 3.05% and a return on equity of 14.36%. Henry Schein has set its FY 2025 guidance at 4.880-4.960 EPS. As a group, research analysts anticipate that Henry Schein will post 4.74 earnings per share for the current year.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.